Originator Organization Oblique Therapeutics ABStartup |
Active Organization Oblique Therapeutics ABStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | Oblique Therapeutics ABStartup | 21 Mar 2022 |